/Companies

Solving RNA therapeutics

2 known investors

Find your way into Solving RNA therapeutics

Sign up to see every warm intro you have to Solving RNA therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Solving RNA therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

TychoBio applies artificial intelligence and computational biology to RNA therapeutics design. The company combines machine learning and biology expertise to develop RNA-based treatments.

Founders & leadership

MD
Mathurin DorelCo-founder

Investors · 2

Frequently asked questions

What does Solving RNA therapeutics do?
TychoBio applies artificial intelligence and computational biology to RNA therapeutics design. The company combines machine learning and biology expertise to develop RNA-based treatments.
Who are Solving RNA therapeutics's investors?
Solving RNA therapeutics's investors include Kima Ventures, Relics Venture.